Z. Tao, A. Shi, and J. Zhao, Epidemiological Perspectives of Diabetes, Cell Biochem Biophys, vol.73, issue.1, pp.181-186, 2015.

U. H. Panton, M. Bagger, and S. Barquera, Projected diabetes prevalence and related costs in three North American urban centres, Public Health, vol.157, pp.43-49, 2015.

M. M. Nentwich and M. W. Ulbig, Diabetic retinopathy -ocular complications of diabetes mellitus, World J Diabetes, vol.6, issue.3, p.489, 2015.

Q. Li, E. Zemel, B. Miller, and I. Perlman, Early retinal damage in experimental diabetes: electroretinographical and morphological observations, Exp Eye Res, vol.74, issue.5, p.615, 2002.

R. Tzekov and G. B. Arden, The electroretinogram in diabetic retinopathy, Surv Ophthalmol, vol.44, issue.1, p.53, 1999.

M. S. Stem and T. W. Gardner, Neurodegeneration in the pathogenesis of diabetic retinopathy: molecular mechanisms and therapeutic implications, Curr Med Chem, vol.20, issue.26, p.3241, 2013.

M. Sharma, I. Nazareth, and I. Petersen, Trends in incidence, prevalence and prescribing in type 2 diabetes mellitus between 2000 and 2013 in primary care: a retrospective cohort study, BMJ Open, vol.6, issue.1, p.10210, 2016.

D. B. Kurland, C. Tosun, and A. Pampori, Glibenclamide for the treatment of acute CNS injury, Pharmaceuticals (Basel), vol.6, issue.10, p.1287, 2013.

H. Kunte, M. A. Busch, and K. Trostdorf, Hemorrhagic transformation of ischemic stroke in diabetics on sulfonylureas, Ann Neurol, vol.72, issue.5, p.799, 2012.

H. Kunte, S. Schmidt, and M. Eliasziw, Sulfonylureas improve outcome in patients with type 2 diabetes and acute ischemic stroke, Stroke, vol.38, issue.9, p.2526, 2007.

N. Caffes, D. B. Kurland, V. Gerzanich, and J. M. Simard, Glibenclamide for the treatment of ischemic and hemorrhagic stroke, Int J MolSci, vol.16, issue.3, p.4973, 2015.

J. Beltrand, C. Elie, and K. Busiah, Sulfonylurea Therapy Benefits Neurological and Psychomotor Functions in Patients With Neonatal Diabetes Owing to Potassium Channel Mutations, Diabetes Care, vol.38, issue.11, p.2033, 2015.

K. Delaunay, L. Khamsy, and L. Kowalczuk, Glial cells of the human fovea, Mol Vis, vol.26, pp.235-245, 2020.

P. Crisanti, O. Laplace, E. Lecain, L. Jonet, J. C. Jeanny et al., The role of PKCzeta in NMDA-induced retinal ganglion cell death: prevention by aspirin, Apoptosis, vol.11, issue.6, p.983, 2006.
URL : https://hal.archives-ouvertes.fr/inserm-00146748

M. Kakizaki and N. Masaki, Spontaneous diabetes produced by selective breeding of normal Wistar rats, Proc. Jpn. Acad, p.51, 1975.

S. Omri, F. Behar-cohen, and P. R. Rothschild, PKCzeta mediates breakdown of outer blood-retinal barriers in diabetic retinopathy, PLoS One, vol.8, issue.11, p.81600, 2013.

S. Omri, F. Behar-cohen, and Y. De-kozak, Microglia/macrophages migrate through retinal epithelium barrier by a transcellular route in diabetic retinopathy: role of PKCzeta in the Goto Kakizaki rat model, Am J Pathol, vol.179, issue.2, p.942, 2011.

E. Kermorvant-duchemin, A. C. Pinel, and S. Lavalette, Neonatal hyperglycemia inhibits angiogenesis and induces inflammation and neuronal degeneration in the retina, PLoS One, vol.8, issue.11, p.79545, 2013.
URL : https://hal.archives-ouvertes.fr/hal-02301188

A. Dobin, C. A. Davis, and F. Schlesinger, STAR: ultrafast universal RNA-seq aligner, Bioinformatics, vol.29, issue.1, pp.15-21, 2013.

B. Li and C. N. Dewey, RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome, BMC bioinformatics, vol.12, p.323, 2011.

M. D. Robinson, D. J. Mccarthy, and G. K. Smyth, edgeR: a Bioconductor package for differential expression analysis of digital gene expression data, Bioinformatics, vol.26, issue.1, pp.139-140, 2010.

J. Simard, M. Chen, and K. Tarasov, Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke, Nat Med, vol.12, issue.4, p.433, 2006.

P. Rothschild, S. Salah, and M. Berdugo, ROCK-1 mediates diabetes-induced retinal pigment epithelial and endothelial cell blebbing: Contribution to diabetic retinopathy, Sci Rep, vol.7, issue.1, p.8834, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02461587

K. Miyamoto, Y. Ogura, and H. Nishiwaki, Evaluation of retinal microcirculatory alterations in the Goto-Kakizaki rat. A spontaneous model of non-insulin-dependent diabetes, Invest Ophthalmol Vis Sci, vol.37, issue.5, p.898, 1996.

K. B. Jonsson, U. Frydkjaer-olsen, and J. Grauslund, Vascular Changes and Neurodegeneration in the Early Stages of Diabetic Retinopathy: Which Comes First?, Ophthalmic Res, vol.56, pp.1-9, 2016.

J. M. Simard, O. Tsymbalyuk, and A. Ivanov, Endothelial sulfonylurea receptor 1-regulated NC Ca-ATP channels mediate progressive hemorrhagic necrosis following spinal cord injury, J Clin Invest, vol.117, issue.8, p.2105, 2007.

J. M. Simard, Z. Geng, and S. K. Woo, Glibenclamide reduces inflammation, vasogenic edema, and caspase-3 activation after subarachnoid hemorrhage, J Cereb Blood Flow Metab, vol.29, issue.2, p.317, 2009.

J. M. Simard, P. G. Popovich, and O. Tsymbalyuk, MRI evidence that glibenclamide reduces acute lesion expansion in a rat model of spinal cord injury, Spinal Cord, vol.51, issue.11, p.823, 2013.

J. M. Simard, P. G. Popovich, O. Tsymbalyuk, and V. Gerzanich, Spinal cord injury with unilateral versus bilateral primary hemorrhage--effects of glibenclamide, Exp Neurol, vol.233, issue.2, p.829, 2012.

J. M. Simard, K. N. Sheth, and W. T. Kimberly, Glibenclamide in cerebral ischemia and stroke, Neurocrit Care, vol.20, issue.2, p.319, 2014.

J. M. Simard, O. Tsymbalyuk, K. Keledjian, A. Ivanov, S. Ivanova et al., Comparative effects of glibenclamide and riluzole in a rat model of severe cervical spinal cord injury, Exp Neurol, vol.233, issue.1, p.566, 2012.

J. M. Simard, S. K. Woo, and N. Tsymbalyuk, Glibenclamide-10-h Treatment Window in a Clinically Relevant Model of Stroke, Transl Stroke Res, vol.3, issue.2, p.286, 2012.

J. M. Simard, V. Yurovsky, N. Tsymbalyuk, L. Melnichenko, S. Ivanova et al., Protective effect of delayed treatment with low-dose glibenclamide in three models of ischemic stroke, Stroke, vol.40, issue.2, p.604, 2009.

C. Tosun, M. T. Koltz, and D. B. Kurland, The protective effect of glibenclamide in a model of hemorrhagic encephalopathy of prematurity, Brain Sci, vol.3, issue.1, p.215, 2013.

B. Schattling, K. Steinbach, E. Thies, M. Kruse, A. Menigoz et al., TRPM4 cation channel mediates axonal and neuronal degeneration in experimental autoimmune encephalomyelitis and multiple sclerosis, Nat Med, vol.18, issue.12, p.1805, 2012.

R. Garg, A. G. Agthe, P. K. Donohue, and C. U. Lehmann, Hyperglycemia and retinopathy of prematurity in very low birth weight infants, J Perinatol, vol.23, issue.3, p.186, 2003.

L. Mohsen, M. Abou-alam, M. El-dib, M. Labib, M. Elsada et al., A prospective study on hyperglycemia and retinopathy of prematurity, J Perinatol, vol.34, issue.6, p.453, 2014.

H. Luan, R. Roberts, M. Sniegowski, D. J. Goebel, and B. A. Berkowitz, Retinal thickness and subnormal retinal oxygenation response in experimental diabetic retinopathy, Invest Ophthalmol Vis Sci, vol.47, issue.1, p.320, 2006.

A. Abdelsaid, M. A. Matragoon, S. Pillai, B. A. El-remessy, and A. B. , Neurovascular protective effect of FeTPPs in N-methyl-D-aspartate model: similarities to diabetes, Am J Pathol, vol.185, issue.6, pp.1795-1801, 2015.

, Am J Pathol, vol.177, issue.3, pp.1187-1197, 2010.

S. Omri, B. Omri, and M. Savoldelli, The outer limiting membrane (OLM) revisited: clinical implications, Clin Ophthalmol, vol.4, pp.183-195, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00472804

C. Y. Gong, B. Lu, Y. C. Sheng, Z. Y. Yu, J. Y. Zhou et al., The Development of Diabetic Retinopathy in Goto-Kakizaki Rat and the Expression of Angiogenesis-Related Signals, Chin J Physiol, vol.59, issue.2, p.100, 2016.

J. Kinukawa, M. Shimura, N. Harata, and M. Tamai, Gliclazide attenuates the intracellular Ca2+ changes induced in vitro by ischemia in the retinal slices of rats with streptozotocininduced diabetes, Curr Eye Res, vol.30, issue.9, pp.789-98, 2005.

G. Jerums, R. M. Murray, and E. Seeman, Lack of effect of gliclazide on early diabetic nephropathy and retinopathy: a two-year controlled study, Diabetes Res Clin Pract, vol.3, issue.2, pp.71-80, 1987.

A. P. Babenko, M. Polak, and H. Cavé, Activating mutations in the ABCC8 gene in neonatal diabetes mellitus, N Engl J Med, vol.355, issue.5, p.456, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00094668

B. P. Walcott, K. T. Kahle, and J. M. Simard, Novel treatment targets for cerebral edema, Neurotherapeutics, vol.9, issue.1, p.65, 2012.

N. Ruzafa, X. Pereiro, M. F. Lepper, S. M. Hauck, and E. Vecino, Proteomics Approach to Identify Candidate Proteins Secreted by Müller Glia that Protect Ganglion Cells in the Retina, Proteomics, vol.18, issue.11, p.1700321, 2018.

A. Vargas, H. S. Kim, E. Baral, W. Q. Yu, C. Craft et al., Protective effect of clusterin on rod photoreceptor in rat model of retinitis pigmentosa, PLoS One, vol.12, issue.8, p.182389, 2017.

C. Zhang, J. Nie, and L. Feng, The emerging roles of clusterin on reduction of both blood retina barrier breakdown and neural retina damage in diabetic retinopathy, Discov Med, vol.21, issue.116, pp.227-264, 2016.

T. Parmar, V. M. Parmar, and L. Perusek, Lipocalin 2 Plays an Important Role in Regulating Inflammation in Retinal Degeneration, J Immunol, vol.200, issue.9, pp.3128-3141, 2018.

J. Zhou, S. Ye, T. Fujiwara, S. C. Manolagas, and H. Zhao, Steap4 plays a critical role in osteoclastogenesis in vitro by regulating cellular iron/reactive oxygen species (ROS) levels and cAMP response element-binding protein (CREB) activation, J. Biol. Chem, vol.288, pp.30064-30074, 2013.

E. Picard, I. Fontaine, and L. Jonet, The protective role of transferrin in Muller glial cells after iron-induced toxicity, Mol Vis, vol.14, pp.928-941, 2008.
URL : https://hal.archives-ouvertes.fr/hal-02657871

E. Picard, L. Rouzic, Q. Oudar, and A. , Targeting iron-mediated retinal degeneration by local delivery of transferrin, Free Radic Biol Med, vol.89, pp.1105-1121, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-02980617

X. Liu, J. J. Xavier, C. Wu, and H. , Glutaredoxin 1 (Grx1) Protects Human Retinal Pigment Epithelial Cells From Oxidative Damage by Preventing AKT Glutathionylation, Invest Ophthalmol Vis Sci, vol.56, pp.2821-2832, 2015.

R. Huang, Q. Lan, and L. Chen, CD200Fc Attenuates Retinal Glial Responses and RGCs Apoptosis After Optic Nerve Crush by Modulating CD200/CD200R1 Interaction, J. Mol. Neurosci. MN, vol.64, pp.200-210, 2018.

Y. Okunuki, R. Mukai, and E. A. Pearsall, Microglia inhibit photoreceptor cell death and regulate immune cell infiltration in response to retinal detachment, ProcNatlAcadSci U S A, vol.3, issue.27, pp.6264-6273, 2018.

N. Lou, T. Takano, Y. Pei, A. L. Xavier, S. A. Goldman et al., Purinergic receptor P2RY12-dependent microglial closure of the injured blood-brainbarrier, ProcNatlAcadSci U SA, vol.26, issue.4, pp.1074-1083, 2016.

D. B. Kurland, V. Gerzanich, and J. K. Karimy, The Sur1-Trpm4 channel regulates NOS2 transcription in TLR4-activated microglia, J Neuroinflammation, vol.13, issue.1, p.130, 2016.

E. Nakajima, L. L. David, C. Bystrom, T. R. Shearer, and M. Azuma, Calpain-specific proteolysis in primate retina: Contribution of calpains in cell death, Invest Ophthalmol Vis Sci, vol.47, pp.5469-5475, 2006.

R. Wen, W. Tao, Y. Li, P. A. Sieving, . Cntf et al., Prog Retin Eye Res, vol.31, pp.136-151, 2012.